InvestSMART

Amplia Therapeutics Limited (ASX: ATX) - Announcements

Current share price for ATX : $0.082 0.002 (2.38%)+

ASX company news and announcements for Amplia Therapeutics Limited (ATX) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Amplia Therapeutics Limited (ATX) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Amplia Therapeutics Limited (ATX), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Amplia Therapeutics Limited (ATX)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$42 Quarterly Activities/Appendix 4C Cash Flow Report 28 Oct 2026 8:22AM $0.079 $0.082 risen by 3.80%
$42 Amplia Receives R&D Tax Rebate Totalling $4.78 Million 22 Oct 2026 1:45PM $0.077 $0.082 risen by 6.49%
$42 Amplia Therapeutics Provides Clinical Trial Updates 22 Oct 2026 8:17AM $0.081 $0.082 risen by 1.23%
$42 Response to ASX Price Query 16 Oct 2026 2:19PM $0.078 $0.082 risen by 5.13%
$42 Amplia Presents at CG Drug and Device Conference 2026 13 Oct 2026 8:18AM $0.110 $0.082 fallen by 25.45%
$42 Amplia Presents at E&P Healthcare Conference 2026 16 Sep 2026 3:05PM $0.125 $0.082 fallen by 34.40%
$42 Amplia and ANZGOG Finalise Protocol for Ovarian Cancer Trial 15 Sep 2026 8:21AM $0.120 $0.082 fallen by 31.67%
$42 Notification regarding unquoted securities - ATX 9 Sep 2026 5:24PM $0.130 $0.082 fallen by 36.92%
$42 Results of Annual General Meeting 28 Aug 2026 12:10PM $0.148 $0.082 fallen by 44.41%
$42 CEO Managing Director Presentation to Annual General Meeting 28 Aug 2026 9:38AM $0.150 $0.082 fallen by 45.33%
$42 Bioshares Biotech Summit Presentation 6 Aug 2026 10:09AM $0.160 $0.082 fallen by 48.75%
$42 Amplia signs Collaboration and Supply Agreement with Lilly 4 Aug 2026 8:22AM $0.135 $0.082 fallen by 39.26%
$42 Scientific Paper Studies of narmafotinib - Pancreatic Cancer 31 Jul 2026 8:33AM $0.125 $0.082 fallen by 34.40%
$42 Quarterly Activities/Appendix 4C Cash Flow Report 29 Jul 2026 8:29AM $0.130 $0.082 fallen by 36.92%
$42 Notice of Annual General Meeting/Proxy Form 27 Jul 2026 4:14PM $0.130 $0.082 fallen by 36.92%
$42 Notification regarding unquoted securities - ATX 15 Jul 2026 6:27PM $0.135 $0.082 fallen by 39.26%
$42 Notification regarding unquoted securities - ATX 15 Jul 2026 6:18PM $0.135 $0.082 fallen by 39.26%
$42 Amplia Therapeutics Shareholder Webinar 13 Jul 2026 9:37AM $0.145 $0.082 fallen by 43.45%
$42 Initial Director's Interest Notice - Brett Carter 6 Jul 2026 4:43PM $0.155 $0.082 fallen by 47.10%
$42 Amplia Announces Appointment of Brett Carter to Board 6 Jul 2026 8:52AM $0.150 $0.082 fallen by 45.33%
$42 Annual General Meeting to be held Friday 28 August 2026 1 Jul 2026 8:20AM $0.145 $0.082 fallen by 43.45%
$42 Amplia Announces Changes to Board's Leadership Roles 30 Jun 2026 8:18AM $0.150 $0.082 fallen by 45.33%
$42 Notice of Initial Substantial Holding from SOL 25 Jun 2026 8:17AM $0.125 $0.082 fallen by 34.40%
$42 Becoming a substantial holder from PCG 24 Jun 2026 2:51PM $0.130 $0.082 fallen by 36.92%
$42 Appendix 4G - Key to Corporate Governance Disclosures 29 May 2026 3:38PM $0.140 $0.082 fallen by 41.43%

1 - 25 of 548 results

Page 1 of 22

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.